Core Viewpoint - BrightSpring Health Services, Inc. is conducting a secondary offering of 15,000,000 shares of common stock, with no shares being sold by the company itself, and the proceeds will go entirely to the selling stockholders [1] Group 1: Offering Details - The offering is expected to close on October 22, 2025, subject to customary closing conditions [1] - The company has authorized the concurrent purchase of 1,500,000 shares from the underwriter at the same price per share as the offering, with the repurchase closing simultaneously with the offering [2] - BofA Securities is acting as the sole book-running manager for the offering, which will be sold at market prices or negotiated prices [3] Group 2: Regulatory Information - A shelf registration statement relating to these securities was filed with the SEC on June 10, 2025, and became effective upon filing [4] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [5]

Core Insights - BrightSpring Health Services, Inc. (BTSG) reported quarterly earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.27 per share, and showing significant growth from $0.11 per share a year ago, resulting in an earnings surprise of +11.11% [1] - The company achieved revenues of $3.33 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.46% and increasing from $2.91 billion year-over-year [2] - BrightSpring Health Services has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Performance - The company has shown a strong performance with a year-to-date stock increase of approximately 74.6%, compared to the S&P 500's gain of 13.3% [3] - The current consensus EPS estimate for the upcoming quarter is $0.34, with expected revenues of $3.31 billion, and for the current fiscal year, the EPS estimate is $1.10 on revenues of $12.5 billion [7] Industry Outlook - The Medical Services industry, to which BrightSpring belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook [8] - The performance of BrightSpring's stock may be influenced by the overall industry outlook, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] Future Expectations - The sustainability of the stock's price movement will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The estimate revisions trend for BrightSpring was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6]

BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance LOUISVILLE, Ky., October 20, 2025 — BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced preliminary financial results for the third quarter ended September 30, 2025, increased Revenue and Adjusted EBITDA 1 guidance, and provided details regardin ...

Core Viewpoint - BrightSpring Health Services, Inc. announced a secondary offering of 15,000,000 shares of common stock by certain stockholders, with no shares being sold by the company itself [1] Group 1: Offering Details - The secondary offering will be conducted by selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain management members [1] - The company has authorized a concurrent share repurchase of up to 10% of the shares sold in the offering or $50 million, whichever is less, at the same price per share as the underwriter [2] - BofA Securities is acting as the sole book-running manager for the offering, which will be sold at market prices or negotiated prices [3] Group 2: Regulatory and Documentation - A shelf registration statement related to these securities was filed with the SEC on June 10, 2025, and became effective upon filing [4] - The offering will be made only by means of a preliminary prospectus supplement and accompanying prospectus, which can be obtained from BofA Securities [5]

Core Insights - BrightSpring Health Services, Inc. reported preliminary financial results for Q3 2025, showing significant revenue growth and improved Adjusted EBITDA guidance [1][2][5] Financial Performance - Total revenue for Q3 2025 reached approximately $3,334 million, a 28.2% increase from $2,601 million in Q3 2024 [5][4] - Gross profit for Q3 2025 was approximately $392 million, up 21.3% from $323 million in Q3 2024 [5][4] - The company achieved a net income of approximately $37.5 million in Q3 2025, compared to a net loss of approximately $25.7 million in Q3 2024 [5][4] - Adjusted EBITDA for Q3 2025 was approximately $160 million, reflecting a 37.2% increase from $117 million in Q3 2024 [5][4] Segment Performance - Pharmacy Solutions revenue for Q3 2025 was $2,967 million, a 31% increase from $2,266 million in Q3 2024 [4][5] - Provider Services revenue for Q3 2025 was $367 million, a 9% increase from $336 million in Q3 2024 [4][5] - Total Adjusted EBITDA for the company was $202 million for Q3 2025, up 33% from $151 million in Q3 2024 [6][5] Future Guidance - The company increased its 2025 revenue guidance to between $12,400 million and $12,700 million, representing a growth of 23.1% to 26.1% compared to 2024 [5][4] - Adjusted EBITDA guidance for 2025 is set between $605 million and $615 million, indicating a growth of 31.5% to 33.7% [5][4] Upcoming Events - BrightSpring will announce full Q3 results on October 28, 2025, and will host a conference call at 4:30 p.m. Eastern Time on the same day [3][1]

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/. FOR MORE INFORMATION: , /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 20. S&P 500 constituent Huntington Bancshares Inc. (NA ...

Core Insights - BrightSpring Health Services, Inc. (BTSG) is positioned to potentially continue its earnings-beat streak in the upcoming report, having surpassed earnings estimates by an average of 76.64% in the last two quarters [1][2]. Earnings Performance - For the last reported quarter, BrightSpring Health Services, Inc. achieved earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.19 per share, resulting in a surprise of 15.79% [2]. - In the previous quarter, the company was expected to post earnings of $0.08 per share but delivered $0.19 per share, leading to a significant surprise of 137.50% [2]. Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for BrightSpring Health Services, Inc., with a positive Zacks Earnings ESP (Expected Surprise Prediction), indicating a strong likelihood of an earnings beat [5][8]. - The current Earnings ESP for BrightSpring Health Services, Inc. is +49.89%, suggesting that analysts have recently become more optimistic about the company's earnings prospects [8]. Zacks Rank and Success Rate - The combination of a positive Earnings ESP and a Zacks Rank 3 (Hold) suggests that the company is likely to beat earnings estimates, with historical data indicating that such combinations result in positive surprises nearly 70% of the time [6][8].

Core Viewpoint - BrightSpring Health Services, Inc. is set to release its third quarter 2025 financial results on October 31, 2025, prior to an earnings conference call scheduled for 8:30 a.m. ET on the same day [1]. Company Overview - BrightSpring Health Services provides home- and community-based pharmacy and provider health solutions for complex populations requiring specialized and chronic care [3]. - The company operates across all 50 states, serving over 460,000 customers, clients, and patients daily through various service lines, including pharmacy, home health care, primary care, rehabilitation, and behavioral health [3]. - BrightSpring has shown strong quality metrics across its service lines, contributing to improved health outcomes for high-need individuals while reducing overall healthcare costs [3].

Summary of BrightSpring Health Services Conference Call Company Overview - BrightSpring Health Services is a leading provider of home and community healthcare services in the U.S. [2] - The company serves approximately 400,000 individuals daily, focusing on high-quality, impactful services [3][4]. Business Segments Pharmacy Platform - The pharmacy platform includes closed-door home and community pharmacy services, specialty pharmacy, and infusion services [3]. - BrightSpring processes over 40 million prescriptions annually, catering to patients with specialized needs [3]. - The specialty pharmacy and oncology business have been significant growth drivers, with expectations of 20%+ growth [11][9]. Provider Platform - The provider platform encompasses home health, rehab, hospice, and personal care services [4]. - The company anticipates a growth rate of 12% to 15% for its provider business this year [9]. - The integration of services allows for better coordination of care, reducing hospitalizations by 50% [4]. Primary Care Platform - The primary care platform focuses on home-based primary care, enhancing care coordination for patients with multiple chronic conditions [30][32]. - The company has entered into value-based care arrangements, showing a 10% to 15% cost reduction with improved outcomes [33]. Financial Performance - BrightSpring has achieved a historical revenue and EBITDA CAGR of 15%, with recent acceleration towards 30% growth this year [7][10]. - The company aims to maintain a mid-teens growth rate moving forward [10]. M&A Strategy - BrightSpring has a history of small tuck-in acquisitions, averaging 10 to 15 deals annually, primarily in the $10 to $15 million EBITDA range [38][41]. - The company has successfully completed 68 deals historically, with a high success rate in increasing EBITDA post-acquisition [41]. Balance Sheet and Deleveraging - The company expects to exit 2025 with a leverage ratio of around 3x, targeting 2x by 2026 [36][43]. - Positive cash flow generation supports deleveraging efforts, with potential for increased acquisition activity in 2026 [36]. Regulatory Environment - BrightSpring is actively engaging with payers regarding potential reimbursement changes due to the IRA, with expectations of manageable impacts [46][48]. - The company anticipates that home health reimbursement will eventually align with the ROI of home health services [48]. Key Takeaways - BrightSpring's integrated service model across pharmacy, provider, and primary care enhances operational efficiencies and patient outcomes [49]. - The company's focus on scale, quality, and technology positions it well within the growing home and community healthcare market [2][4]. - BrightSpring's strategic approach to M&A and capital deployment aims to sustain growth while maintaining a healthy balance sheet [38][43].

Core Insights - BrightSpring Health Services, Inc. (NASDAQ:BTSG) is recognized as one of the 11 best-performing IPOs in the last two years, with a significant price target elevation by analysts following a strong second quarter performance and improved revenue and adjusted EBITDA guidance [1][2]. Financial Performance - The company reported a 29% year-over-year revenue growth, reaching $3.1 billion for Q2 2025 [2]. - Revenue in its Pharmacy Solutions segment grew by 32% year-over-year, with specialty scripts increasing by 38% [2]. - Following this performance, the company raised its revenue and adjusted EBITDA guidance for 2025, indicating a positive outlook [2]. Analyst Ratings and Price Targets - Analysts have raised their price targets for BTSG, with Deutsche Bank increasing it from $25 to $30 and Bank of America from $27.50 to $31 [3]. - The consensus rating for the stock remains a Buy, reflecting strong market confidence [3]. Company Background - BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Kentucky, specializing in home and community-based health and pharmacy services for individuals with complex health needs [4]. Stock Performance - Since its IPO, BTSG has demonstrated significant growth, with a total growth percentage of 147.09% to date [3].